Stereotactic radiation therapy for hepatic malignancies.

Area of Science:

• Hepatology and Radiation Oncology
• Tumor Ablation Techniques

Background:

• Liver tumor management requires multidisciplinary input.
• Radiation therapy's role in liver tumors is expanding due to technological advancements.
• Stereotactic body radiation therapy (SBRT) shows promise for liver malignancies.

Purpose of the Study:

• To review the evolving role of SBRT in liver tumor treatment.
• To discuss key aspects of liver SBRT, including toxicity, planning, and clinical outcomes.
• To compare SBRT with other non-surgical ablative therapies.

Main Methods:

• Literature review focusing on SBRT for primary and secondary liver tumors.
• Analysis of radiation-induced hepatic toxicity.
• Evaluation of SBRT treatment planning and clinical results.
• Comparison with alternative non-surgical ablative methods.

Main Results:

• SBRT is becoming a more significant treatment modality for liver tumors.
• Understanding and managing radiation-induced hepatic toxicity is crucial for SBRT.
• Clinical outcomes demonstrate the efficacy of SBRT in selected liver tumor cases.
• SBRT offers a competitive non-surgical ablative option.

Conclusions:

• SBRT represents a significant advancement in the non-surgical management of liver tumors.
• Further research is needed to optimize SBRT protocols and expand its application.
• SBRT is a viable and evolving treatment option within a multidisciplinary approach to liver cancer.